Citation Impact
Citing Papers
( R )-2-Hydroxyglutarate Is Sufficient to Promote Leukemogenesis and Its Effects Are Reversible
2013 StandoutScienceNobel
2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk
2013 Standout
Myocardial infarction in young women with special reference to oral contraceptive practice.
1975
Relationships Between Authors of Clinical Practice Guidelines and the Pharmaceutical Industry
2002 Standout
Regression of Coronary Artery Disease as a Result of Intensive Lipid-Lowering Therapy in Men with High Levels of Apolipoprotein B
1990 Standout
Chronic Venous Disease
2006 Standout
The SREBP Pathway: Regulation of Cholesterol Metabolism by Proteolysis of a Membrane-Bound Transcription Factor
1997 StandoutNobel
Cardiovascular Disease Outcomes During 6.8 Years of Hormone Therapy
2002 Standout
Levels and physicochemical properties of lipoprotein subclasses in moderate hypertriglyceridemia
1993
The metabolic syndrome
2010 Standout
Beyond Cholesterol
1989 Standout
Molecular basis of human hypertension: Role of angiotensinogen
1992 Standout
Hemostatic Factors and the Risk of Myocardial Infarction or Sudden Death in Patients with Angina Pectoris
1995 Standout
Mutation in the Gene Coding for Coagulation Factor V and the Risk of Myocardial Infarction, Stroke, and Venous Thrombosis in Apparently Healthy Men
1995 Standout
Cardiovascular Effects of n-3 Fatty Acids
1988 Standout
The metabolic syndrome
2005 Standout
Reporting standards in venous disease: An update
1995 Standout
Effects of fibrates on serum lipids and atherosclerosis
1988
A prospective study of the incidence of deep‐vein thrombosis within a defined urban population
1992
Effects of Diet and Simvastatin on Serum Lipids, Insulin, and Antioxidants in Hypercholesterolemic Men
2002
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
Meta-Analysis of the Effects of Soy Protein Intake on Serum Lipids
1995 Standout
Reduction of Serum Cholesterol with Sitostanol-Ester Margarine in a Mildly Hypercholesterolemic Population
1995 Standout
Changes in Energy Expenditure Resulting from Altered Body Weight
1995 Standout
High density lipoprotein cholesterol and arteriography in intermittent claudication
1989
Wine, alcohol, platelets, and the French paradox for coronary heart disease
1992 Standout
Differential Impact of Blood Pressure–Lowering Drugs on Central Aortic Pressure and Clinical Outcomes
2006 Standout
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
1987 Standout
Effects of ethanol on lipid metabolism.
1979
FREQUENCY OF RISK FACTORS FOR ISCHÆMIC HEART-DISEASE IN A HEALTHY BRITISH POPULATION
1974
Increased Plasma Levels of a Rapid Inhibitor of Tissue Plasminogen Activator in Young Survivors of Myocardial Infarction
1985
Altitude, radiation, and mortality from cancer and heart disease.
1987
Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent.
1980 Standout
PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE
1975 Standout
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
Cholesterol-Lowering and HDL-Raising Properties of Lecithinated Soy Proteins in Type II Hyperlipidemic Patients
1985
Effects of Weight Reduction on Obesity STUDIES OF LIPID AND CARBOHYDRATE METABOLISM IN NORMAL AND HYPERLIPOPROTEINEMIC SUBJECTS
1974
Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction.
1987 Standout
Arterial hemodynamics in human hypertension.
1986
ISCHÆMIC HEART-DISEASE IN RELATION TO FASTING VALUES OF PLASMA TRIGLYCERIDES AND CHOLESTEROL
1972
Hyperlipidemia in Coronary Heart Disease II. GENETIC ANALYSIS OF LIPID LEVELS IN 176 FAMILIES AND DELINEATION OF A NEW INHERITED DISORDER, COMBINED HYPERLIPIDEMIA
1973 StandoutNobel
Genetics of the LDL receptor: Evidence that the mutations affecting binding and internalization are allelic
1977 StandoutNobel
PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTION
1987
Immunoassay of human plasma apolipoprotein B
1975
Concentration of lipoproteins containing apolipoprotein B in human peripheral lymph
1977
Atherogenesis: a postprandial phenomenon.
1979 Standout
Plant sterols as cholesterol-lowering agents: Clinical trials in patients with hypercholesterolemia and studies of sterol balance
1977
Conversion of very low density lipoprotein to low density lipoprotein. A metabolic study of apolipoprotein B kinetics in human subjects.
1975
Regulation of Plasma Cholesterol by Lipoprotein Receptors
1981 StandoutScienceNobel
Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group.
1993 Standout
The mechanism of the reaction between human plasminogen-activator inhibitor 1 and tissue plasminogen activator
1990 StandoutNobel
Hyperlipidemia in Coronary Heart Disease III. EVALUATION OF LIPOPROTEIN PHENOTYPES OF 156 GENETICALLY DEFINED SURVIVORS OF MYOCARDIAL INFARCTION
1973 StandoutNobel
A Receptor-Mediated Pathway for Cholesterol Homeostasis
1986 StandoutScienceNobel
The metabolism of the apoprotein of plasma low density lipoprotein in familial hype rbetalipoproteinaemia in the homozygous form
1975
Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ
1997 Standout
LIPID ABNORMALITIES IN MALE AND FEMALE SURVIVORS OF MYOCARDIAL INFARCTION AND THEIR FIRST-DEGREE RELATIVES
1972
ACAT2 Is Localized to Hepatocytes and Is the Major Cholesterol-Esterifying Enzyme in Human Liver
2004 StandoutNobel
Familial Hypercholesterolemia: Identification of a Defect in the Regulation of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Activity Associated with Overproduction of Cholesterol
1973 StandoutNobel
NEONATAL DIAGNOSIS OF FAMILIAL TYPE-II HYPERLIPOPROTEINÆMIA
1973
Soybean protein diets in the management of type II hyperlipoproteinaemia
1985
Splanchnic Metabolism of Plasma Apolipoprotein B
1981
Broad-β disease versus endogenous hypertriglyceridemia: Levels and lipid composition of chylomicrons and very low density lipoproteins during fat-free feeding and alimentary lipemia
1975
MULTICENTRE STUDY OF SOYBEAN PROTEIN DIET FOR OUTPATIENT HYPERCHOLESTEROLÆMIC PATIENTS
1980
Aortocoronary Saphenous Vein Graft Disease
1998 Standout
Is decreased activity of C-II activated lipoprotein lipase in type III hyperlipoproteinemia (broad-β-disease) a cause or an effect of increased apolipoprotein E levels?
1976
Estrogen and Coronary Heart Disease in Women
1991 Standout
Reporting standards in venous disease
1988
Investigation of Chronic Venous Insufficiency
2000 Standout
The Epidemiology of Venous Thromboembolism
2003 Standout
Dietary and Drug Treatment of Primary Hyperlipoproteinemia
1972
Management of hyperlipidaemia: guidelines of the British Hyperlipidaemia Association
1993
FAMILY STUDY OF SERUM LIPIDS AND LIPOPROTEINS IN CORONARY HEART-DISEASE
1973
Role of Insulin Resistance in Human Disease
1988 Standout
Familial Hypercholesterolemia in a Large Kindred
1972 StandoutNobel
Catabolism of Very Low Density Lipoprotein B Apoprotein in Man
1978
Type III Hyperlipoproteinemia: An Analysis of Two Contemporary Definitions
1975
LIPID NEPHROTOXICITY IN CHRONIC PROGRESSIVE GLOMERULAR AND TUBULO-INTERSTITIAL DISEASE
1982 Standout
Venous thrombosis: a multicausal disease
1999 Standout
Investigation of Genetic Linkage in Human Families
1987
Hyperlipidemia in Coronary Heart Disease I. LIPID LEVELS IN 500 SURVIVORS OF MYOCARDIAL INFARCTION
1973 StandoutNobel
Triglyceride-lowering effect of marine polyunsaturates in patients with hypertriglyceridemia.
1985
Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition
1979 StandoutNobel
Haemostatic Factors and Inhibitors and Coronary Artery Bypass Grafting: Preoperative Alterations and Relations to Graft Occlusion
1994
SERUM HIGH-DENSITY LIPOPROTEINS IN PERIPHERAL VASCULAR DISEASE
1978
Coronary heart disease — The global picture
1975
Plasma lipids and atherosclerosis.
1973
FREQUENCY OF ISCHÆMIC EXERCISE E.C.G. CHANGES IN SYMPTOM-FREE MEN WITH VARIOUS FORMS OF PRIMARY HYPERLIPÆMIA
1975
Human Aging: Usual and Successful
1987 StandoutScience
Liver Transplantation to Provide Low-Density-Lipoprotein Receptors and Lower Plasma Cholesterol in a Child with Homozygous Familial Hypercholesterolemia
1984 StandoutNobel
Biologically active low density lipoprotein in human peripheral lymph.
1978 StandoutNobel
Relationship among the concentrations of serum lipoproteins and changes in their chemical composition in patients with untreated nephrotic syndrome
1977
Works of Z Fejfar being referenced
"Risk factors" in ischaemic heart disease.
1972
[Classification of hyperlipidemias and hyperlipoporteinemias. II].
1972
Classification of Hyperlipidaemias and Hyperlipoproteinaemias ,
1972
WHO's work in cardiovascular diseases: a brief review.
1971
Epidemiological aspects of thrombosis and vascular disease.
1966
Changes of Cardiac Output in Hypertensive Disease
1957